KRAS-targeted multi-peptide vaccine(CK Life Sciences)

N/A

Report date: 2024/07/12 15:24:40

Base Information

Drug NameKRAS-targeted multi-peptide vaccine(CK Life Sciences)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog modulatorsProgrammed death-ligand 1 modulators
TargetsGTPase KRasProgrammed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCk Life Sciences Int'L (Holdings) Inc
China Registration ClassN/A

Develop Information

Active CompaniesCk Life Sciences Int'L (Holdings) Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A